1Schwartz JS, Song P, Blitzer A. Spasmodic dysphonia[M]. In: Cooper G,Eds. Therapeutic uses of Botulinum toxin, totowa. NJ: Humana Press inc, 2007. 110-112.
2Schweinfurth JM, Billante M, Courey MS. Risk factors and demographics in patients with spasmodic dysphonia[J]. Laryngoscope, 2002, 112 : 220.
3Tisch SHD, Brake NM, Law M, et al. Spasmodic dysphonic: clinical features and effects of botulinum toxin therapy in 169 patients-an Australian experience [J]. Journal of Clinical Neuroscience, 2003, 10:434.
7Ginsberg BI, Wallack J J, Srain J J, et al. Defining the psychiatric role in spastic dysphonia[J]. General Hospital Psychiatry, 1988, 10: 132.
8Dedo HH, Behlau MB. Recurrent laryngeal nerve section for spastic dysphonia: 5- to 14-year prelininary results in the first 300 patients[J]. Ann otol Rhinol Laryngol, 1991, 100: 274.
9Blitzer A. Spasmodic dysphonia and botulium toxin: experience from the largest treatment series[J]. Eur J Neurol, 2010, 17:28.
10Langeveld TP,Drost HA. Unilateral versus bilateral botulinum toxin injections in adductor spasmodic dysphonia[J]. Ann Orol Rhinlo Laryngol, 1998, 107: 280.
5Blitzer A, Brin MF, Stewart CF . Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia) : a 12-year experience inmore than 900 patients. Laryngoscope, 1998,108 : 1435-1441.
6Boutsen F, Cannito MP, Taylor M, et al. Botox treatment in adductor spasmodic dysphonia: a mcta-analysis. J Speech Lang Hear Rcs ,2002,45:469-481.
7Klotz DA, Maronian NC, Waugh PF , et aL Findings of multiple muscle involvement in a study of 214 patients with laryngeal dystonia using fine-wire electromyography. Ann Otol Rhinol Laryngol,2004,113: 602-612.
9Hillel AD, Maronian NC, Waugh PF, et al. Treatment of the interarytenoid muscle with botulinum toxin for laryngeal dystonla.Ann Otol Rhinol Laryngol,2004, 113:341-348.
10Hillel AD. The study of laryngeal muscle activity in normal human subjects and in patients with laryngeal dystonia using multiple finewire electromyography. Laryngoscope, 2001,111:1-47.
6Muny T. Spasmodic Dysphonia: Let' s Look at That Again. J Voice, 2014, 28 (6) : 694-699.
7Blitzer A, Brin M, Fahn S, et al. The use of Botulinum tox?in in the treatment of focal laryngeal dystonia (spastic Dyspho?nia). Laryngoscope, 1988, 98: 193.
8Chen S. Clinical uses of botulinum neurotoxins: current indi?cations, limitations and future developments. Toxins (Ba?sel) , 2012,4(10): 913-939.
